Syngenta Enters License Agreement For Chromatin Gene Stacking Technology
Published:26-June-2009
By Staff Reporter
Obtained exclusive rights to use chromatin’s stacking technology
Syngenta Biotechnology (Syngenta) has entered into a research and commercial license agreement for Chromatin's gene stacking technology in sugar cane.
Under this agreement, Syngenta has obtained exclusive rights to use Chromatin's stacking technology for trait genes in all members of the genus Saccharum. It includes commercial sugar cane varieties as well as energy cane, and crosses between Saccharum and other plant species. Syngenta obtained non-exclusive rights for use of this stacking technology in corn and soybean in 2007.
Ian Jepson, Global R&D sugar cane crop lead, said: "Sugar cane growers and processors will benefit economically and environmentally from access to a combination of advanced traits that this technology could make. This new stacking technology, combined with the advanced plant varieties, crop protection choices, and our revolutionary new Plene technology will ensure our customers will have the best solutions in sugar cane and will give us a leading position especially in the large Brazilian market."
Daphne Preuss, President and CEO, Chromatin, said: "Chromatin is pleased to continue our work with Syngenta. The broad Syngenta pipeline and crop production programs make them an ideal partner for us in applying Chromatin's gene stacking technology in sugar cane worldwide."
